BiotechTube
Home/Aldeyra Therapeutics/Todd C. Brady
TC

Todd C. Brady

President, CEO & Chairman

Aldeyra Therapeutics

Therapeutic Areas

OphthalmologyImmunology

Aldeyra Therapeutics Pipeline

DrugIndicationPhase
ReproxalapDry Eye DiseaseNDA Submitted
ADX-2191Primary Vitreoretinal LymphomaPhase 3
ADX-629Systemic Immune-Mediated DiseasesPhase 2a

Leadership Team at Aldeyra Therapeutics

DJ
David J. Clark
Chief Medical Officer
JR
Joshua Reed
Chief Financial Officer & Treasurer
SG
Stephen G. Machatha
Chief Development Officer
BH
Ben H. McGraw III
Chief Commercial Officer
View full Aldeyra Therapeutics profile